Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Condensed nanofat with fat grafts effectively improves atrophic facial scars.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.